Table 1.
The distribution of pain routine treatment in all studied subjects – patients were grouped based on the strongest analgesic type
| Routine step 1 : nonopioids | Routine step 2: weak opioids | Routine step 3: strong opioids | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Schedule of treatment | Name of the drug and the daily dosage | APS | CMAI | Schedule of treatment | Name of the drug and the daily dosage | APS | CMAI | Schedule of treatment | Name of the drug and the daily dosage | APS | CMAI |
| Acetaminophen | Acetaminophen 500 mg 1. 1-0-0 2. 1-0-1 3. 1-0-1 4. 1-0-0 5. 1-0-1 6. 1-0-0 7. 1-0-1 8. 1-0-1 9. 0-0-1 10. 1-1-1 |
3 4 0 6 0 3 2 1 8 0 |
29 32 52 57 44 32 46 32 51 39 |
Tramadol 37.5 mg/acetaminophen 325 mga 1. 1-0-1 2. 1-0-1 3. 1-0-1 4. 1-0-1 5. 1-0-1 |
16 0 0 9 2 |
80 31 29 35 35 |
Buprenorphine 35 μg/hb 1 patch/3 days |
117 | 57 | ||
| Buprenorphine 52.5 fig/hb 1 patch/3 days |
7 | 29 | |||||||||
| Buprenorphine 35 fig/hb 1 patch/3 day + naproxen 250 mg: 0-0-1 |
13 | 29 | |||||||||
| NSAIDs | Ibuprofen 200 mg: 1-0-0 | 6 | 34 | Tramadol 75 mg/acetaminophen 650 mga1. 0-0-1 2. 1-0-1 |
7 11 |
29 45 |
|||||
| Diclofenac 150 mg: 1-0-0 | 6 | 47 | Tramadol 37.5 mg/acetaminophen 325 mg:a 1-0-1 + diclofenac 50 mg: 1-0-0 |
1 | 29 | ||||||
| Diclofenac 75 mg: 1-0-0 | 1 | 32 | Tramadol 75 mg/acetaminophen 650 mg:a 0-0-1 | 12 | 29 | ||||||
| Naproxen 250 mg: 1 -0-0 | 14 | 70 | |||||||||
Note:
a
One therapeutic formula,
b
transdermal patch.
Abbreviations: APS, Abbey Pain Scale; CMAI, Cohen–Mansfield Agitation Inventory Scale; NSAID, nonsteroidal anti-inflammatory drug.